Hansa Biopharma AB is a biopharmaceutical company based in Lund, Sweden, that develops enzyme-based medicines for patients with rare immunological conditions. Its main product is an antibody-cleaving enzyme used to prepare highly sensitised patients for kidney transplantation by removing antibodies that would otherwise cause rejection. The company also studies the same technology in other immune-mediated diseases, working with transplant centres, clinicians and specialist hospital customers.
On this site Hansa Biopharma AB appears as a stock on the Stockholm Exchange (Sweden), code HNSA, with prices in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #184 of 912 on the Stockholm Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Sweden yet.
TrendStrong
75/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average7.3%
From 52-week high-21.2%
MomentumStrong
83/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return19.9%
6-month return47.9%
12-month, skipping last month5.1%
Stability (higher is calmer)Weak
44/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)64.1%
Worst drawdown, 1 year (smaller is calmer)-39.3%
LiquidityStrong
85/100
Trades actively.
See the numbers →
Avg daily value traded22.27M SEK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Sweden when fundamentals data for this market is added. All Sweden stocks.
52-wk range 23.52 – 48.22Daily closes, split-adjusted
Signals
50-day average38.58
200-day average34.30
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.67
Technical summary
Daily
Strongly bullish
11 bullish · 3 neutral · 2 bearish
Weekly
Strongly bullish
9 bullish · 1 neutral · 2 bearish
Monthly
Bullish
5 bullish · 1 neutral · 2 bearish
Moving averages (daily)
SMA 10
36.45
Bullish
EMA 10
36.49
Bullish
SMA 20
35.08
Bullish
EMA 20
36.20
Bullish
SMA 50
38.58
Bearish
EMA 50
36.77
Bullish
SMA 100
36.56
Bullish
EMA 100
36.24
Bullish
SMA 200
34.30
Bullish
EMA 200
34.85
Bullish
Oscillators (daily)
RSI (14)
51.92
Neutral
MACD (12, 26)
0.00
Bullish
Momentum (12)
8.75
Bullish
Stochastic %K (14)
67.81
Neutral
Williams %R (14)
-32.19
Neutral
CCI (20)
103.6
Bearish
Pivot points (classic, last session)
S3
34.92
S2
35.80
S1
36.30
Pivot
37.18
R1
37.68
R2
38.56
R3
39.06
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in SEK. Educational only, not financial advice.
